Difficult-to-treat asthma: how far to investigate?

Authors
Citation
J. De Blic, Difficult-to-treat asthma: how far to investigate?, REV FR ALLE, 40(7), 2000, pp. 742-746
Citations number
20
Categorie Soggetti
Clinical Immunolgy & Infectious Disease
Journal title
REVUE FRANCAISE D ALLERGOLOGIE ET D IMMUNOLOGIE CLINIQUE
ISSN journal
03357457 → ACNP
Volume
40
Issue
7
Year of publication
2000
Pages
742 - 746
Database
ISI
SICI code
0335-7457(200011)40:7<742:DAHFTI>2.0.ZU;2-G
Abstract
Difficult-to-treat asthma (DTA) is an heterogeneous condition associated wi th uncontrolled asthma despite optimum treatment. Management of DTA in chil dren requires: 1)to exclude alternative diagnosis (vocal cord dysfunctionin g, cystic fibrosis, primary ciliary dyskinesia, hypereosinophilia, bronchop ulmonary dysplasia, sequelae of viral infection); 2) to assess compliance, underuse of asthma medication being the main cause of avoidable DTA; and 3) to look for either precipitating or environmental factors, gastroesophagea l reflux, or sinusitis. Medical teatment is based upon optimization of educ ation and association of antiinflammatory and bronchodilator drugs. (C) 200 0 Editions scientifiques et medicales Elsevier SAS.